Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-γ- and interleukin-4- induced activation of human keratinocytes

Journal of Investigative Dermatology

Volumn 115, Issue 1, 2000, Pages 81-87

  Albanesi, Cristina ^a   Scarponi, Claudia ^a   Cavani, Andrea ^a   Federici, Monica ^a   Nasorri, Francesca ^a   Girolomoni, Giampiero ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Allergic contact dermatitis; Cytokines; Skin inflammation

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 6;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; KERATINOCYTE; LYMPHOCYTE CLONE; PRIORITY JOURNAL; SKIN ALLERGY; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 0033911218     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00041.x     Document Type: Article

References (42)

1. Aarvak T, Chabaud M, Miossec P, Natvig JB: IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 162:1246-1251, 1999
2. Albanesi C, Cavani A, Girolomoni G: Interferon-γ-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MIIC class II molecules. J Invest Dermatol 110:138-142, 1998a
3. Albanesi C, Pastore S, Fanales-Belasio E, Girolomoni G: Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy 28:101-109, 1998b
4. Albanesi C, Cavani A, Girolomoni G: IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonistic effects with IFN-γ and TNF-α. J Immunol 162:494-502, 1999
5. Antonysamy MA, Fanslow WC, Fu F, Li W, Qian S, Troutt AB, Thomson AW: Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 162:577-584, 1999
6. Arend WP, Malyak M, Guthridge CJ, Gabay C: Interleukin-1 receptor antagonist: role in biology. Ann Rev Immunol 16:27-55, 1998
7. Bach EA, Aguet M, Schreiber RD: The IFN-γ receptor: a paradigm for cytokine receptor signaling. Ann Rev Immunol 15:563-591, 1997
8. Barker JN, Sarma V, Mitra RS, Dixit VM, Nickoloff BJ: Marked synergism between tumor necrosis factor-α and interferon-γ in regulation of keratinocyte-derived adhesion molecules and chemotactic factor. J Clin Invest 85:605-608, 1990
9. Bigler CF, Norris DA, Weston WL, Arend WP: Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98:38-44, 1992
10. + T cells. J Invest Dermatol 111:621-628, 1998
11. + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 114:295-302, 2000
12. Chabaud M, Fossiez F, Taupin J, Miossec P: Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 161:409-414, 1998
13. Costa JJ, Demetri GD, Harrist TJ, et al: Recombinant human stem cell factor (Kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vitro. J Exp Med 183:2681-2686, 1996
14. Debets R, Hegmans JPJJ, Croughs P, Troost RJJ, Prins JB, Benner R, Prens EP: The IL-1 system in psoriatic skin. IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 158:2955-2963, 1997
15. Fossiez F, Djossou O, Chomarat P, et al: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593-2603, 1996
16. Groves RW, Rauschmayr T, Nakamura K, Sarkar S, Williams IR, Kupper TS: Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. J Clin Invest 98:336-344, 1996
17. Hammerberg C, Arend WP, Fisher GJ, et al: Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 90:571-583, 1992
18. Jovanovic DV, Di Battista DA, Martel-Pelletier J, et al: IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α, by human macrophages. J Immunol 160:3513-3521, 1998
19. Junghans V, Jung T, Neumann C: Human keratinocytes constitutively express IL-4 receptor molecules and respond to IL-4 with an increase in B7/BB1 expression. Exp Dermatol 5:316-324, 1996
20. Kondo S, Pastore S, Fujisawa H, Shivji GM, McKenzie MC, Dinarello CA, Sauder DN: Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J Invest Dermatol 105:334-338, 1995
21. Kulke R, Todt-Pingel I, Rademacher D, Rowert J, Schroder JM, Christophers E: Colocalized overexpression of GRO-α and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. J Invest Dermatol 106:526-530, 1996
22. Kupper TS, Groves RW: The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 105:62S-66S, 1995
23. Laan M, Cui Z-H, Hoshino H, et al: Neutrophil recruitment by human IL-17 via CXC chemokine release in the airways. J Immunol 162:2347-2352, 1999
24. Li H, Chen J, Huang A, et al: Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA 97:773-778, 2000
25. Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S, Link H: Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5:101-104, 1999
26. Mullarkey MF, Leiferman KM, Peters MS, et al: Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor. J Immunol 152:2033-2041, 1994
27. Muzio M, Polentarutti N, Facchetti F, et al: Characterization of type II intracellular IL-1 receptor agonist (IL-1ra3): a depot of IL-1ra. Eur J Immunol 29:781-788, 1999
28. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE: The IL-4 receptor: signaling, mechanisms and biologic functions. Ann Rev Immunol 17:701-738, 1999
29. Pastore S, Corinti S, La Placa M, Didona B, Girolomoni G: Interferon-γ promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J Allergy Clin Immunol 101:538-544, 1998
30. Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DY: Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-γ. J Invest Dermatol 99:403-408, 1992
31. Rouvier E, Luciani M, Mattei M, Denizot F, Golstein P: CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a Herpesvirus saimiri gene. J Immunol 150:5445-5456, 1993
32. Schlaak JF, Buslau M, Jochum W, et al: T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102:145-149, 1994
33. Schwarzenberger P, La Ruissa V, Miller A, et al: IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 161:6383-6389, 1998
34. Serpier H, Gillery P, Salmon-Ehr V, Garnotel R, Georges N, Kalis B, Maquart FX: Antagonistic effects of interferon-γ and interleukin-4 on fibroblast cultures. J Invest Dermatol 109:158-162, 1997
35. Szepietowskj JC, McKenzie RC, Keohane SG, Aldridge RD, Hunter JA: Atopic and non-atopic individuals react to nickel challenge in a similar way. a study of the cytokine profile in nickel-induced contact dermatitis. Br J Dermatol 137:195-200, 1997
36. Teunissen MBM, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD: Interleukin-17 and interferon-γ synergize in the enhancement of proinnammatory cytokine production by human keratinocytes. J Invest Dermatol 111:645-649, 1998
37. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 97:389-394, 1991
38. Viac J, Gueniche A, Gatto H, Lizard G, Schmitt D: Interleukin-4 and interferon-γ interactions in the induction of intercellular adhesion molecule-1 and major histocompatibility complex class II antigen expression of normal human keratinocytes. Exp Dermatol 3:72-77, 1994
39. Werfel T, Morita A, Grewe M, Renz H, Wahn U, Krutmann J, Kapp A: Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 107:871-876, 1996
40. Werfel T, Hentschel M, Kapp A, Renz H: Dichotomy of blood- and skin-derived IL-4-producing allergen-specific T cells and restricted Vβ repertoire in nickel-mediated contact dermatitis. J Immunol 158:2500-2505, 1997
41. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RT: Human IL-17: a novel cytokine derived from T cells. J Immunol 155:5483-5486, 1995
42. Yao Z, Spriggs MK, Derry JM, et al: Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9:794-800, 1997